Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for AKI in Living Donor Liver Transplantation
NCT03522688Phase 4Unknown
- Sponsor
- Asan Medical Center
- Start
- Jul 2017
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in acute kidney injury (AKI), sponsored by Asan Medical Center. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT03522688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03522688.